Composition
- Active ingredients
- TRIPLE SULFA (SULFABENZAMIDE 184MG; SULFACETAMIDE 143.75MG; SULFATHIAZOLE) 172.5MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- TRIPLE SULFA (SULFABENZAMIDE 3.7%; SULFACETAMIDE 2.86%; SULFATHIAZOLE) 3.42% · CreamANDA087285-001 · Discontinued
- TRIPLE SULFA (SULFABENZAMIDE 3.7%; SULFACETAMIDE 2.86%; SULFATHIAZOLE) 3.42% · CreamANDA086424-001 · Discontinued
- TRIPLE SULFA (SULFABENZAMIDE 184MG; SULFACETAMIDE 143.75MG; SULFATHIAZOLE) 172.5MG · TabletANDA088462-001 · Discontinued
- TRIPLE SULFA (SULFABENZAMIDE 3.7%; SULFACETAMIDE 2.86%; SULFATHIAZOLE) 3.42% · CreamANDA087864-001 · Discontinued
- TRIPLE SULFA (SULFABENZAMIDE 184MG; SULFACETAMIDE 143.75MG; SULFATHIAZOLE) 172.5MG · TabletThis page
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA088463.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Triple Sulfa
- Active substance
- triple sulfa (sulfabenzamide
- Route
- Vaginal
- Dosage form
- Tablet
- Applicant
- Fougera
- Status
- Discontinued
- Application
- ANDA088463-001